| Number: | 97878111 | Filing Date: | 09/12/2024 |
|---|---|---|---|
| Status: | Terminated | Status Date: | 12/11/2024 |
| General Contact Number: | 571-272-8500 | ||
| Paralegal Name: | LALITA R WEBB | ||
| Opposition #: | |||
|---|---|---|---|
| Defendant | |||||||||
| Name: | Amgen Inc. | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Correspondence: | ELSA D. LEMOINE AMGEN INC. ONE AMGEN CENTER DRIVE, TRADEMARK OPERATIONS MS-28-5A THOUSAND OAKS, CA 91320-1799 UNITED STATES elemoine@amgen.com, tmops@amgen.com Phone: 805-447-3278 |
||||||||
| Serial #: | 97878111 | Application File | Assignment | ||||||
| Application Status: | ABANDONED - EXPRESS AFTER PUB | ||||||||
| Mark: | BIMTUVIQ | ||||||||
| Potential Opposer | |||||||||
| Name: | Regeneron Pharmaceuticals, Inc. | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Correspondence: | PAUL C. LLEWELLYN ARNOLD & PORTER KAYE SCHOLER LLP 250 WEST 55TH STREET NEW YORK, NY 10019-9710 UNITED STATES trademarkdocketing@arnoldporter.com, Paul.Llewellyn@arnoldporter.com, Amit.Kesar@arnoldporter.com Phone: 212-836-7828 |
||||||||
| Granted To Date: | 12/11/2024 | ||||||||
| Prosecution History | ||||
|---|---|---|---|---|
| # | Date | History Text | ||
| 4 | 10/08/2024 | EXT GRANTED | ||
| 3 | 10/08/2024 | ADD'L 60-DAY REQUEST TO EXT TIME TO OPPOSE | ||
| 2 | 09/12/2024 | EXT GRANTED | ||
| 1 | 09/12/2024 | FIRST 30-DAY REQUEST TO EXT TIME TO OPPOSE | ||